Cartesian Therapeutics, Inc.

RNAC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$212,610$76,911$106,438$114,057
Short-Term Investments$0$0$28,164$13,998
Receivables$872$8,851$9,858$9,914
Inventory$0$0$0$0
Other Curr. Assets$3,144$4,967$3,678$6,474
Total Curr. Assets$216,626$90,729$148,138$144,443
Property Plant & Equip (Net)$15,447$12,181$14,411$11,971
Goodwill$48,163$48,163$0$0
Intangibles$150,600$150,600$0$0
Long-Term Investments$2,000$2,000$2,000$2,000
Tax Assets$0$0$0$0
Other NC Assets$2,187$1,377$1,337$1,469
Total NC Assets$218,397$214,321$17,748$15,440
Other Assets$0$0$0$0
Total Assets$435,023$305,050$165,886$159,883
Liabilities
Payables$288$3,150$316$224
Short-Term Debt$2,851$2,166$10,084$7,010
Tax Payable$0$0$0$601
Deferred Revenue$0$2,311$593$53,883
Other Curr. Liab.$19,837$60,582$14,084$10,533
Total Curr. Liab.$22,976$68,209$25,077$72,251
LT Debt$11,133$8,789$27,841$28,271
Deferred Rev, NC$0$3,538$0$11,417
Deferred Tax Liab, NC$16,141$322,081$0$0
Other NC Liab.$391,575$342,617$19,140$25,423
Total NC Liab.$418,849$677,025$46,981$65,111
Other Liabilities$0$0$0$0
Cap. Leases$13,984$10,955$11,663$9,647
Total Liabilities$441,825$745,234$72,058$137,362
Equity
Pref Stock$0$0$0$0
Common Stock$3$16$15$12
Retained Earnings-$692,071-$614,647-$394,937-$430,316
AOCI-$4,621-$4,600-$4,558-$4,566
Other Equity$689,887$179,047$493,308$457,391
Total Equity-$6,802-$440,184$93,828$22,521
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$435,023$305,050$165,886$159,883
Net Debt-$198,626-$65,956-$68,513-$78,776
Cartesian Therapeutics, Inc. (RNAC) Financial Statements & Key Stats | AlphaPilot